UROLITHIASIS-AN UPDATED REVIEW OVER GENETICS, PATHOPHYSIOLOGY AND ITS CLINICAL MANAGEMENT
Keywords:
Calculi, Diagnosis, Etiopathogenesis, Genetical, Management, MultifactorialAbstract
Urolithiasis is the formation of renal calculi within the urinary tract of susceptible individual of various etiopathogenic factors with a complex pathogenic manifestation. It is a worldwide problem which was evident from the ancient times of Egyptian period. It is the third most urinary disorder with a lifetime risk of 15-25% and the prevalence rate of 3-5%. In the management of urolithiasis, the clinicians face a deprived status of mind with its multifactorial etiopathogenesis. Thus the exact therapy still remains to be debated with this modest understanding of pathophysiology and genetical aspects of urolithiasis. As a result of these poor understandings, an attempt was made to detail the multifactorial etiopathogenesis and genetical aspects of urolithiasis with a view to advancement in the clinical management. Moreover to this attempt, this review also summarized the updated clinical management in terms of specific and surgical measures along with its differential diagnosis to the extent of intending an immense sound over its management to the clinicians.
Downloads
References
Divakar K, Pawar AT, Chandrasekhar SB, Dighe SB, Divakar G. Protective effect of the hydro-alcoholic extract of Rubia cordifolia roots against ethylene glycol induced urolithiais in rats. Food Chem Toxicol 2010;48:1013-1018.
Bouanani S, Henchiri C, MigianuGriffoni E, Aouf N, Lecouve M. Pharmacological and toxicological effects of Paronychia argentea in experimental calcium oxalate nephrolithiasis in rats. J Ethnopharmacol 2010;129:38–45.
Alessandra CP, Elvino JGB. Dietary calcium intake among patients with urinary calculi. Nutr Res 2003;23:1651–60.
Osborne CA, Lulich JP, Swanson LL, Albasan H. Drug-Induced Urolithiasis. Vet Clin North Am Small Anim Pract 2009;39(1):55–63.
Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med 2010;363(10):954-63.
Saha S, Verma RJ. Inhibition of calcium oxalate crystallization in vitro by an extract of Bergenia ciliate. Arab J Urol 2013;11(2):187-92.
Karadi RV, Gadge NB, Alagawadi KR, Savadi RV. Effect of Moringa oleifera Lam. Root-wood on ethylene glycol induced urolithiasis in rats. J Ethnopharmacol 2005;105:306-11.
Lewandowski S, Rodgers AL. Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment. Clin Chim Acta 2004;345:17–34.
Daudon M, Dore JC, Jungers P, Lacour B. Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 2004;32(3):241–7.
Rizvi SA, Naqvi SA, Hussain Z. Pediatric urolithiasis: developing nation perspectives. J Urol 2002;168:1522–5.
Hussain M, Rizvi SA, Askari H, Sultan G, Lal M, Ali B, et al. Management of stone disease: 17 years experience of a stone clinic in a developing country. J Pak Med Assoc 2009;59(12):843–46.
Senthy S, Christoper F. The metabolic basis of urolithiasis. Surgery 2008;26(4):136-40.
Grases F, Costa-Bauza A, Ramis M, Montesinos V, Conte A. Simple classification of renal calculi closely related to their micromorphology and etiology. Clin Chim Acta 2002;322:29-36.
Das I, Gupta SK, Ansari SA, Pandey VN, Rastogi RP. In vitro inhibition and dissolution of calcium oxalate by edible plant Trianthema monogyna and pulse Macrotyloma uniflorum extracts. J Cryst Growth 2005;273:546-54.
Moe OW. Kidney stones: pathophysiology and medical management. Lancet 2006;367:333-44.
Pak CY, Kaplan R, Bone H, Townsend J, Waters O. A simple test for the diagnosis of absorptive, resportive and renal hypercalciurias. N Eng J Med 1975;292(10):497–500.
Sakhaee K, Harvey JA, Padalino PK, Whitson P, Pak CY. The potential role of salt abuse on the risk for kidney stone formation. J Urol 1993;150:310–12.
Cirillo M, Ciacci C, Laurenzi M, Mellone M, Mazzacca G, De Santo NG. Salt intake, urinary sodium, and hypercalciuria. Miner Electrolyte Metab 1997;23:265–68.
Pak CY, Poindexter JR, Adams-Huet B, Pearle MS. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003;115(1):26–32.
Robertson WG, Heyburn PJ, Peacock M, Hanes FA, Swaminathan R. The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci (Lond) 1979;57(3):285–88.
Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328(12):833–38.
Reddy ST, Wang CY, Sakhaee K, Brinkley L, Pak CY. Effect of low carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis 2002;40(2):265–74.
Amanzadeh J, Gitomer WL, Zerwekh JE, Preisig PA, Moe OW, Pak CY, et al. Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int 2003;64(6):2142–49.
Pak CY. Citrate and renal calculi: new insights and future directions. Am J Kidney Dis 1991;17(4):420–25.
Pak CY, Adams-Huet B, Poindexter JR, Pearle MS, Peterson RD, Moe OW. Relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int 2004;66(5):2032–37.
Grases F, Prieto R, Tur JA. Dietary effects upon calcium oxalate urolithiasis risk. Int Urol Nephrol 1992;24(5):495-501.
Griffith DP, Osborne CA. Infection (urease) stones. Miner Electrolyte Metab 1987;13(4):278-85.
Bichler KH, Eipper E, Naber K, Braun V, Zimmermann R, Lahme S. Urinary infection stones. Int J Antimicrob Agents 2002;19(6):488-98.
Schwartz BF, Stoller ML. Non surgical management of infection related renal calculi. Urol Clin North Am 1999;26(4):765-78.
Wong HY, Riedl CR, Griffith DP. Medical management and prevention of struvite stones. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM, editors. Kidney Stones: Medical and Surgical Management. New York: Raven Press; 1996. p. 941-50.
Cameron MA, Sakhaee K. Uric acid nephrolithiasis. Urol Clin North Am 2007;34(3):335–46.
Yü TF. Nephrolithiasis in patients with gout. Postgrad Med 1978;63(5):164–70.
Pak CY, Sakhaee K, Peterson RD, Poindexter JR, Frawley WH. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 2001;60(2):757–61.
Pak CY, Poindexter JR, Peterson RD, Koska J, Sakhaee K. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis. Urology 2002;60(5):789–94.
Sakhaee K, Adams-Huet B, Moe OW, Pak CY. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 2002;62(3):971–79.
Cameron MA, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 2006;17(5):1422-8.
Mehta TH, Goldfarb DS. Uric acid stones and hyperuricosuria. Adv Chronic Kidney Dis 2012;19(6):413-8.
Hall PM. Nephrolithiasis: Treatment, causes and prevention. Cleve Clin J Med 2014;76(10):583-91.
Palacin M, Nunes V, Font-Llitjós M, Jiménez-Vidal M, Fort J, Gasol E, et al. The genetics of heteromeric amino acid transporters. Physiology (Bethesda) 2005;20:112–24.
Knoll T, Zollner A, Wendt-Nordahl G, Michel MS, Alken P. Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 2005;20(1):19–24.
HanchanaleVS, Biyani CS, Browning AJ, Joyce AD. Topiramate and the risk of urolithiasis. BJU Int 2011;107(3):352-4.
Wirth GJ, Teuscher J, Graf JD, Iselin CE. Efavirenz-induced urolithiasis. Urol Res 2006;34(4):288-9.
Mittal RD, Mishra DK, Srivastava P, Manchanda P, Bid HK, Kapoor R. Polymorphism in the vitamin D receptor and androgen receptor gene associated with the risk of urolithiasis. Indian J Clin Biochem 2010;25(2):119-26.
Chen WC, Chen HY, Lu HF, Hsu CD, Tsai FJ. Association of the vitamin D receptor gene start codon Fok I polymorphism with calcium oxalate stone disease. BJU Int 2001;87(3):168-71.
Jackman SV, Kibel AS, Ovuworie CA, Moore RG, Kavoussi LR, Jarrett TW. Familial calcium stone disease: TaqI polymorphism and the vitamin D receptor. J Endourol 1999;13(4):313-6.
Pacifici R, Rothstein M, Rifas L, Lau KH, Baylink DJ, Avioli LV, et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 1990;71(1):138-45.
Chen WC, Wu HC, Chen HY, Wu MC, Hsu CD, Tsai FJ. Interleukin-1β gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones. Urol Res 2001;29(5):321-4.
Lin HY, Harris TL, Flannery MS, Aruffo A, Kaji EH, Gorn A, et al. Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Sci 1991;254(5034):1022-4.
Chen WC, Wu HC, Lu HF, Chen HY, Tsai FJ. Calcitonin receptor gene polymorphism: a possible genetic marker for patients with calcium oxalate stones. Eur Urol 2001;39(6):716-9.
Van Aswegen CH, Dirksen van Sckalckwyk JC, du Toit PJ, Verster L, Franz RC, du Plessis DJ. The effect of calcium and magnesium ions on urinary urokinase and sialidase activity. Urol Res 1992;20(1):41-4.
Tripputi P, Blasi F, Verde P, Cannizzaro LA, Emanuel BS, Croce CM. Human urokinase gene is located on the long arm of chromosome 10. Proc Natl Acad Sci U S A 1985;82(13):4448-52.
Tsai FJ, Lin CC, Lu HF, Chen HY, Chen WC. Urokinase gene 3’-UTR T/C Polymorphism is associated with Urolithiasis. Urol 2002;59(3):458-61.
Mittal RD, Bid HK, Kumar A, Bhandari M. Association of urokinase gene 3'-UTR polymorphism with calcium oxalate nephrolithiasis. J Endourol 2006;20(2):157-60.
Becker KF, Reich U, Schott C, Hofler H. Single nucleotide polymorphism in the human E-cadherin gene. Hum Genet 1995;96(6):739-40.
Tsai FJ, Wu HC, Chen HY, Lu HF, Hsu CD, Chen WC. Association of E-Cadherin Gene 3‘-UTR C/T polymorphism with calcium oxalate stone disease. Urol Int 2003;70(4):278-81.
Chen WC, Chen HY, Wu HC, Wu MC, Hsu CD, Tsai FJ. Vascular endothelial growth factor gene polymorphism is associated with calcium oxalate stone disease. Urol Res 2003;31(3):218-22.
Mittal RD, Bid HK, Manchanda PK, Kapoor R. Predisposition of genetic polymorphism with the risk of urolithiasis. Indian J Clin Biochem 2008;23(2):106-16.
Chen WC, Lu HF, Chen HY, Hsu CD, Tsai FJ. Arginine form of p21 gene codon 31 is less prominent in patients with calcium oxalate stone. Urol Res 2001;29(2):94-7.
Dal Moro, Mancini M, Tavolini IM, De Marco V, Bassi P. Cellular and molecular gateways to urolithiais: A new insight. Urol Int 2005;74(3):193-7.
Yuen YP, Lam CW, Lai CK, Tong SF, Li PS, Tam S, et al. Heterogeneous mutations in the SLC3A1 and SLC7A9 genes in Chinese patients with cystinuria. Kidney Int 2006;69(1):123-8.
Simmonds HA. 2,8-dihydroxyadenine lithiasis. Clin Chim Acta 1986;160(2):103-8.
Chen WC, Wu HC, Lin WC, Wu MC, Hsu CD, Tsai FJ. The association of androgen and oestrogen-receptor gene polymorphisms with urolithiasis in men. BJU Int 2001;88(4):432-6.
Worcester EM, Coe FL. Nephrolithiasis. Prim Care 2008;35(2):369–91.
Miller NL, Evan AP, Lingeman JE. Pathogenesis of renal calculi. Urol Clin North Am 2007;34(3):295–313.
Kim SC, Coe FL, Tinmouth WW, Kuo RL, Paterson RF, Parks JH, et al. Stone formation is directly proportional to papillary surface coverage by Randall’s plaque. J Urology 2005;178:117-9.
Ryall RL. The scientific basis of calcium oxalate urolithiasis. World J Urol 1993;11(1):59-65.
Walters DC. Stress as a principle cause of calcium oxalate urolithiasis. Int Urol Nephrol 1986;18(3):271-5.
Maalouf NM. Metabolic Syndrome and the Genesis of Uric Acid Stones. J Ren Nutr 2011;21(1):128-31.
Maalouf NM, Cameron MA, Moe OW, Sakhaee K. Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 2004;13(2):181–9.
Michell AR. Urolithiasis-historical, comparative and pathophysiological aspects: a review. J Soc Med 1989;82(11):669-72.
Bihl G, Meyers A. Recurrent renal stone disease—advances in pathogenesis and clinical management. Lancet 2001;358(9282):651-6.
Adhirai M, Selvam R. Renal calcium oxalate binding protein: studies on its properties. Kidney Int 1998;53(1):125–9.
Thomas B, Hall J. Urolithiasis. Surgery 2005;23(4):129-33.
Nakada SY, Jerde TJ, Bjorling DE, Saban R. Selective cyclooxygenase-2 inhibitors reduce ureteral contraction in vitro: a better alternative for renal colic? J Urol 2000;163(2):607–12.
Martins M, Meyers AM, Whalley MA, Margolius LP, Buys ME. Indapamide: the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria. Br J Urol 1996;78(2):176–80.
Hanson KA. Management of calcium oxalate stones. Clin Excell Nurse Pract 2001;5(1):21–5.
Ruml LA, Pearle MS, Pak CYC. Medical therapy: calcium oxalate urolithiasis. Urol Clin North Am 1997;24(1):117-33.
Kenny JE, Goldfarb DS. Update on the pathophysiology and management of uric acid stones. Curr Rheumatol Rep 2010;12(2):125-29.
Griffith DP, Gleeson MJ, Lee H, Longuet R, Deman E, Earle N. Randomized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi. Eur Urol 1991;20(3):243–7.
Williams JJ, Rodman JS, Peterson CM. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med 1984;311(12):760–4.
Joly D, Rieu P, Mejean A, Gagnadoux M, Daudon M, Jungers P. Treatment of cystinuria. Pediatr Nephrol 1999;13(9):945–50.
Birwe H, Schneeberger W, Hesse A. Investigations of the efficacy of ascorbic acid therapy in cystinuria. Urol Res 1991;19(3):199–201.
Pearle MS, Asplin JR, Coe FL, Rodgers A, Worcester EM. Medical management of urolithiasis. In: Denstedt J, Khoury S, editors. International consultation on stone disease. 2nd ed. Paris: Health Publications; 2008. p. 57–84.
Koll T, Pearle MS. Clinical management of urolithiasis. In: Straub M, editor. Pharmacological stone prevention. New York: Springer-Verlag Berlin Heidelberg; 2013. p. 211-21.
Lingeman JE. Lithotripsy and Surgery. Semin Nephrol 1996;16(5):487–98.
Prasad KVSRG, Sujatha D, Bharathi K. Herbal drugs in urolithiasis–a review. Pharmacogn Rev 2007;1(1):175–9.
Tombolini P, Ruoppolo M, Bellorofonte C, Zaatar C, Follini M. Lithotripsy in the treatment of urinary lithiasis. J Nephrol 2000;13(3):S71–S82.
Aggarwal A, Singla SK, Tandon C. Urolithiasis: Phytotherapy as an adjunct therapy. Indian J Exp Biol 2014;53:103-11.
Aggarwal A, Tandon S, Singla SK, Tandon C. Reduction of oxalate-induced renal tubular epithelial (NRK-52E) cell injury and inhibition of calcium oxalate crystallisation in vitro by aqueous extract of Achyranthes aspera. Int J Green Pharm 2010;4(3):159-64.
Aggarwal A, Singla SK, Gandhi M, Tandon C. Preventive and curative effects of Achyranthes aspera Linn. extract in experimentally induced nephrolithiasis. Indian J Exp Biol 2012;50(3):201-8.
Selvam R, Kalaiselvi P, Govindaraj A, Bala Murugan V, Sathish Kumar AS. Effect of A. lanata leaf extract and Vediuppu chunnam on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria. Pharmacol Res 2001;43(1):89-93.
Soundararajan P, Mahesh R, Ramesh T, Begum VH. Effect of Aerva lanata on calcium oxalate urolithiasis in rats. Indian J Exp Biol 2006;44(12):981-6.
Ahmadi M, Rad AK, Rajaei Z, Hadjzadeh MA, Mohammadian N, Tabasi NS. Alcea rosea root extract as a preventive and curative agent in ethylene glycol-induced urolithiasis in rats. Indian J Pharmacol 2012;44(3):304-7.
Khan ZA, Assiri AM, Al-Afghani HM, Maghrabi TM. Inhibition of oxalate nephrolithiasis with Ammi visnaga (Al-Khillah). Int Urol Nephrol 2001;33(4):605-8.
Bashir S, Gilani AH, Siddiqui AA, Pervez S, Khan SR, Sarfaraz NJ, et al. Beriberis vulgaris root bark extract prevents hyperoxaluria induced urolithiasis in rats. Phytother Res 2010;24(8):1250-5.
Bashir S, Gilani AH. Antiurolithic effect of Bergenia ligulata rhizome: an explanation of the underlying mechanisms. J Ethnopharmacol 2009;122(1):106-16.
Yasir F, Waqar MA. Effect of indigenous plant extracts on calcium oxalate crystallization having a role in urolithiasis. Urol Res 2011;39(5):345-50.
Gadge NB, Jalalpure SS. Curative treatment with extracts of Bombax ceiba fruit reduces risk of calcium oxalate urolithiasis in rats. Pharm Biol 2012;50(3):310-7.
Jeong BC, Kim BS, Kim JI, Kim HH. Effects of green tea on urinary stone formation: an in vivo and in vitro study. J Endourol 2006;20:356-61.
Oussama A, Touhami M, Mbarki M. In vitro and in vivo study of effect of lemon juice on urinary pathogenesis. Arch Esp Urol 2005;58(10):1087-92.
Touhami M, Laroubi A, Elhabazi K, Loubna F, Zrara I, Eljahiri Y, et al. Lemon juice has protective activity in a rat urolithiasis model. BMC Urol 2007;7:18.
Goldfarb DS, Asplin JR. Effect of grape fruit juice on urinary lithogenicity. J Urol 2001;166(1):263-7.
Trinchieri A, Lizzano R, Bernardini P, Nicola M, Pozzoni F, Romano AL, et al. Effect of acute load of grape fruit juice on urinary excretion of citrate and urinary risk factors for renal stone formation. Dig Liver Dis 2002;34(2):S160-3.
Raut AA, Sunder S, Sarkar S, Pandita NS, Vaidya AD. Preliminary study on crystal dissolution activity of Rotula aquatica, Commiphora wightii and Boerhaavia diffusa extracts. Fitoterapia 2008;79:544-7.
Chauhan CK, Joshi MJ, Vaidya AD. Growth inhibition of struvite crystals in the presence of herbal extract Commiphora wightii. J Mater Sci Mater Med 2009;20(1):S85-92.
Araújo Viel T, Diogo Domingos C, da Silva Monteiro AP, Riggio Lima-Landman MT, Lapa AJ, Souccar C. Evaluation of the antiurolithiatic activity of the extract of Costus spiralis Roscoe in rats. J Ethnopharmacol 1999;66(2):193-8.
Varalakshmi P, Shamila Y, Latha E. Effect of Crataeva nurvala in experimental urolithiasis. J Ethnopharmacol 1990;28(3):313-21.
Khajavi Rad A, Hadjzadeh MA, Rajaei Z, Mohammadian N, Valiollahi S, Sonei M. The beneficial effect of cynodon dactylon fractions on ethylene glycol-induced kidney calculi in rats. Urol J 2011;8(3):179-84.
Atmani F, Khan SR. Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro. BJU Int 2000;85(6):621-5.
Atmani F, Slimani Y, Mimouni M, Aziz M, Hacht B, Ziyyat A. Effect of aqueous extract from Herniaria hirsuta L. on experimentally nephrolithiasic rats. J Ethnopharmacol 2004;95(1):87-93.
Atmani F, Slimani Y, Mbark N, Bnouham M, Ramdani A. In vitro and in vivo antilithiasic effect of saponin rich fraction isolated from Herniaria hirsuta. J Bras Nefrol 2006;28(4):199-203.
Laikangbam R, Damayanti Devi M. Inhibition of calcium oxalate crystal deposition on kidneys of urolithiatic rats by Hibiscus sabdariffa L. extract. Urol Res 2012;40(3):211-8.
Takawale RV, Mali VR, Kapase CU, Bodhankar SL. Effect of Lagenaria siceraria fruit powder on sodium oxalate induced urolithiasis in Wistar rats. J Ayurveda Integr Med 2012;3(2):75-9.
Nizami AN, Rahman MA, Ahmed NU, Islam MS. Whole Leea macrophylla ethanolic extract normalizes kidney deposits and recovers renal impairments in an ethylene glycol-induced urolithiasis model of rats. Asian Pac J Trop Med 2012;5(7):533-8.
Poonguzhali PK, Chegu H. The influence of banana stem extract on urinary risk factors for stones in normal and hyperoxaluric rats. Br J Urol 1994;74(1):23-5.
Hadjzadeh MA, Khoei A, Hadjzadeh Z, Parizady M. Ethanolic extract of nigella sativa L seeds on ethylene glycol-induced kidney calculi in rats. Urol J 2007;4(2):86-90.
Khan A, Bashir S, Khan SR, Gilani AH. Antiurolithic activity of Origanum vulgare is mediated through multiple pathways. BMC Complement Altern Med 2011;11:96.
Akanae W, Tsujihata M, Yoshioka I, Nonomura N, Okuyama A. Orthosiphon grandiflorum has a protective effect in a calcium oxalate stone forming rat model. Urol Res 2010;38(2):89-96.
Saeidi J, Bozorgi H, Zendehdel A, Mehrzad J. Therapeutic effects of aqueous extracts of Petroselinum sativum on ethylene glycol-induced kidney calculi in rats. Urol J 2012;9(1):361-6.
Barros ME, Lima R, Mercuri LP, Matos JR, Schor N, Boim MA. Effect of extract of Phyllanthus niruri on crystal deposition in experimental urolithiasis. Urol Res 2006;34(6):351-7.
Freitas AM, Schor N, Boim MA. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation. BJU Int 2002;89(9):829-34.
Nishiura JL, Campos AH, Boim MA, Heilberg IP, Schor N. Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients. Urol Res 2004;32(5):362-6.
Hosseinzadeh H, Khooei AR, Khashayarmanesh Z, Motamed-Shariaty V. Antiurolithiatic activity of Pinus eldarica medw: fruits aqueous extract in rats. Urol J 2010;7(4):232-7.
Jose MA, Ibrahim, Janardhanan S. Modulatory effect of Plectranthus amboinicus Lour on ethylene glycol-induced nephrolithiasis in rats. Indian J Pharmacol 2005;37(1):43-4.
Tugcu V, Kemahli E, Ozbek E, Arinci YV, Uhri M, Erturkuner P, et al. Protective effect of a potent antioxidant, pomegranate juice, in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Endourol 2008;22(12):2723-31.
Rathod NR, Biswas D, Chitme HR, Ratna S, Muchandi IS, Chandra R. Anti-urolithiatic effects of Punica granatum in male rats. J Ethnopharmacol 2012;140(2):234-8.
Moriyama MT, Miyazawa K, Noda K, Oka M, Tanaka M, Suzuki K. Reduction in oxalate-induced renal tubular epithelial cell injury by an extract from Quercus salicina Blume/Quercus stenophylla Makino. Urol Res 2007;35(6):295-300.
Moriyama MT, Suga K, Miyazawa K, Tanaka T, Higashioka M, Noda K, et al. Inhibitions of urinary oxidative stress and renal calcium level by an extract of Quercus salicina Blume/Quercus stenophylla Makino in a rat calcium oxalate urolithiasis model. Int J Urol 2009;16(4):397-401.
Vargas R, Perez RM, Perez S, Zavala MA, Perez C. Antiurolithiatic activity of Raphanus sativus aqueous extract on rats. J Ethnopharmacol 1999;68(1-3):335-8.
Geetha K, Manavalan R, Venkappayya D. Control of urinary risk factors of stone formation by Salvadora persica in experimental hyperoxaluria. Methods Find Exp Clin Pharmacol 2010;32(9):623-9.
Doddola S, Pasupulati H, Koganti B, Prasad KV. Evaluation of Sesbania grandiflora for antiurolithiatic and antioxidant properties. J Nat Med 2008;62(3):300-7.
Patel PK, Patel MA, Vyas BA, Shah DR, Gandhi TR. Antiurolithiatic activity of saponin rich fraction from the fruits of Solanum xanthocarpum Schrad. & Wendl. (Solanaceae) against ethylene glycol induced urolithiasis in rats. J Ethnopharmacol 2012;144(1):160-70.
Chaudhary A, Singla SK, Tandon C. In vitro Evaluation of Terminalia arjuna on calcium phosphate and calcium oxalate crystallization. Indian J Pharm Sci 2010;72(3):340-5.
Tayal S, Duggal S, Bandyopadhyay P, Aggarwal A, Tandon S, Tandon C. Cytoprotective role of the aqueous extract of Terminalia chebula on renal epithelial cells. Int Braz J Urol 2012;38(2):204-13.
Sangeeta D, Sidhu H, Thind SK, Nath R. Effect of Tribulus terrestris on oxalate metabolism in rats. J Ethnopharmacol 1994;44(2):61-6.
Anand R, Patnaik GK, Kulshreshtha DK, Dhawan BN. Activity of certain fractions of Tribulus terrestris fruits against experimentally induced urolithiasis in rats. Indian J Exp Biol 1994;32(8):548-52.
Aggarwal A, Tandon S, Singla SK, Tandon C. Diminution of oxalate induced renal tubular epithelial cell injury and inhibition of calcium oxalate crystallization in vitro by aqueous extract of Tribulus terrestris. Int Braz J Urol 2010;36(4):480-8.
Laroubi A, Touhami M, Farouk L, Zrara I, Aboufatima R, Benharref A, et al. Prophylaxis effect of Trigonella foenum graecum L. seeds on renal stone formation in rats. Phytother Res 2007;21(10):921-5.
McHarg T, Rodgers A, Charlton K. Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation. BJU Int 2003;92(7):765-8.